Chemicals and Drugs

Coronavirus Protease Inhibitors

Protease inhibitors that specifically inhibit one or more of the proteases that are produced by CORONAVIRUSES.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

Protease inhibitors that specifically inhibit one or more of the proteases that are produced by CORONAVIRUSES.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

Synonyms

2 entry terms
  • Inhibitors, Coronavirus Protease
  • Protease Inhibitors, Coronavirus

MeSH Record

Aspects Covered

30 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2021

MeSH Record

Previous Indexing

  • Protease Inhibitors (1966-2020)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Coronavirus Protease Inhibitors. Medical Subject Headings (MeSH). 2026. Unique ID D000085683. http://id.nlm.nih.gov/mesh/2026/D000085683
  2. Coronavirus Protease Inhibitors. In: Wikidata. https://www.wikidata.org/wiki/Q114785331